Resmed Inc. buy UBS Group AG
Start price
22.05.23
/
50%
€210.60
Target price
22.05.24
-
Performance (%)
-3.75%
End price
23.05.24
€202.70
Summary
This prediction ended on 23.05.24 with a price of €202.70. With a performance of -3.75%, the BUY prediction by UBS_Group_AG finished with a loss. A total of €1.78 was paid as dividends for this prediction. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 2.698% | 2.698% | -3.441% |
| iShares Core DAX® | 0.039% | 0.567% | 12.281% |
| iShares Nasdaq 100 | -4.018% | -5.554% | 23.851% |
| iShares Nikkei 225® | -2.389% | -1.434% | 8.335% |
| iShares S&P 500 | -2.115% | -2.351% | 22.061% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten